The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (preLights)
Abstract
No abstract available
Article activity feed
-
-
Excerpt
How to fight HPV-induced cancer? In this preprint, Luna et al. investigated this possibility by testing two clinically approved drugs to stop HPV at its early replication stage.
-
-